Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 30)

H-INDEX

(FIVE YEARS 0)

Published By Springer Singapore

9789811591570, 9789811591587

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_14 ◽

2021 ◽

pp. 167-177

Author(s):

Yoshitaka Sekido

Keyword(s):

Targeted Therapies ◽

Molecular Aberrations

Download Full-text

Biomarkers for Immune Checkpoint Inhibitors in Mesothelioma: What Are the Roles of Biomarkers for Optimal Immune Therapy?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_23 ◽

2021 ◽

pp. 267-278

Author(s):

Toshiyuki Minami ◽

Takashi Kijima

Keyword(s):

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Immune Therapy

Download Full-text

Antiangiogenic Therapies for Mesothelioma: What Is the Role in Mesothelioma Treatment?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_21 ◽

2021 ◽

pp. 243-252

Author(s):

Wieneke Buikhuisen ◽

Paul Baas

Keyword(s):

Antiangiogenic Therapies

Download Full-text

Biomarkers for Mesothelioma Screening: How Can We Identify Subjects Developing Mesothelioma in Asbestos-Exposed High-Risk Group?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_5 ◽

2021 ◽

pp. 55-63

Author(s):

Okio Hino ◽

Masaaki Abe ◽

Masataka Kojima ◽

Kazunori Kajino

Keyword(s):

High Risk ◽

Risk Group ◽

High Risk Group

Download Full-text

Cytopathologic Diagnosis of Mesothelioma: Can We Diagnose Mesothelioma Based on Fluid Cytological Materials Without Biopsy?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_10 ◽

2021 ◽

pp. 113-123

Author(s):

Kazuki Nabeshima ◽

Makoto Hamasaki ◽

Yoshiaki Kinoshita ◽

Masayo Yoshimura ◽

Shinji Matsumoto

Download Full-text

Palliative Treatment in Mesothelioma: How to Manage Clinical Symptoms in Mesothelioma

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_19 ◽

2021 ◽

pp. 223-232

Author(s):

Helen Clayson

Keyword(s):

Palliative Treatment ◽

Clinical Symptoms

Download Full-text

Surgery and Adjuvant or Neoadjuvant Setting of Radiotherapy: What Is the Role of Radiotherapy in Combination with Lung-Sparing Surgery?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_28 ◽

2021 ◽

pp. 333-344

Author(s):

Fumihiro Tanaka ◽

Kazue Yoneda

Download Full-text

Tunneled Catheters or Pleurodesis: How Can We Palliate Effusions for Patients with Malignant Pleural Mesothelioma?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_15 ◽

2021 ◽

pp. 181-189

Author(s):

Shamus R. Carr ◽

Joseph S. Friedberg

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

Impact of Radiation Therapy on Malignant Mesothelioma: Are We Ready for Use in Clinical Practice, Combined with Surgery or Alone?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_26 ◽

2021 ◽

pp. 305-318

Author(s):

Keiko Shibuya

Keyword(s):

Radiation Therapy ◽

Clinical Practice ◽

Malignant Mesothelioma

Download Full-text

Asbestos and Mesothelioma: What Is Recent Advance in Research on Asbestos-Induced Molecular Carcinogenesis?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements ◽

10.1007/978-981-15-9158-7_2 ◽

2021 ◽

pp. 17-31

Author(s):

Marie-Claude Jaurand ◽

Clément Meiller ◽

Didier Jean

Keyword(s):

Molecular Carcinogenesis

Download Full-text

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease ManagementsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer Singapore

Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?

Biomarkers for Immune Checkpoint Inhibitors in Mesothelioma: What Are the Roles of Biomarkers for Optimal Immune Therapy?

Antiangiogenic Therapies for Mesothelioma: What Is the Role in Mesothelioma Treatment?

Biomarkers for Mesothelioma Screening: How Can We Identify Subjects Developing Mesothelioma in Asbestos-Exposed High-Risk Group?

Cytopathologic Diagnosis of Mesothelioma: Can We Diagnose Mesothelioma Based on Fluid Cytological Materials Without Biopsy?

Palliative Treatment in Mesothelioma: How to Manage Clinical Symptoms in Mesothelioma

Surgery and Adjuvant or Neoadjuvant Setting of Radiotherapy: What Is the Role of Radiotherapy in Combination with Lung-Sparing Surgery?

Tunneled Catheters or Pleurodesis: How Can We Palliate Effusions for Patients with Malignant Pleural Mesothelioma?

Impact of Radiation Therapy on Malignant Mesothelioma: Are We Ready for Use in Clinical Practice, Combined with Surgery or Alone?

Asbestos and Mesothelioma: What Is Recent Advance in Research on Asbestos-Induced Molecular Carcinogenesis?

Malignant Pleural Mesothelioma - Respiratory Disease Series: Diagnostic Tools and Disease Managements
Latest Publications